Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases
... targeted to the eye from being absorbed into
the blood stream. This new delivery system is a ... I.V. drip (i.e. systemically) or by an injection into
the eyeball (i.e. intravitreal), both of which ... Because the drug is being administered directly into
the eye and not systemically, chemotherapy dosage ...
Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
... pipeline by moving at least two additional drugs into
development in 2009; one new drug has already moved into
development this year
... milestone payment.
Isis entered into
a license agreement with Alnylam, which provided ...
Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
... Foundation said today that it has entered into
a novel collaborative research agreement with the ... JDRF to speed the translation of basic research into
drugs and treatments for type 1 diabetes," said ... of JDRF-funded projects and other discoveries into
"Through this collaboration ...
CTMM Becomes One of the World's Largest Public-Private Partnerships in Translational Medical Research
... With today's final
approval of a research project into
prostate cancer, the Dutch CTMM (Center
for ... translational molecular
medicine research into
innovative new techniques for the diagnosis ... potential to translate research
clinical practice. CTMM is funded by the Dutch ...
Medigus and Tower Semiconductor Announce World's Smallest Medical Video Camera Based on Advanced CMOS Image Sensor
... in the world, designated to be incorporated into
or used in various ... CMOS image sensor process
and will be integrated into
the camera which will be produced in ... class pixel performance, have allowed
us to get into
this very high margin market which will be ...
Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs
... move is consistent with Lilly's transformation into
a fully integrated pharmaceutical network ...
IMC-11F8 is expected to move into
Phase III development by the end of 2009;
... or early 2010;
IMC-3G3 has recently moved into
Phase II development with a study in ovarian ...
July 2009 Mayo Clinic Women's HealthSource Highlights Food Storage Safety, Energy Therapies and Vitamins and Minerals
... leftovers safely. Hot foods can go straight into
the refrigerator or freezer. They shouldn't be ... a large pot will cool more quickly when divided into
smaller, shallower containers. In general, ... known, but others are gradually being integrated into
health care practices in the United States.
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus
... and commercialization agreement entered into
in August 2006.
"Lupus is a chronic, ... for the development of B-lymphocyte cells into
mature plasma B cells. Plasma B cells produce ... GSK
In August 2006, HGS and GSK entered into
a definitive co-development and ...
Cystic Fibrosis - Liposomal Tobramycin Receives Second Orphan Drug Designation Within Weeks
... action, which allows the antibiotics to penetrate into
bacteria, Fluidosomes(TM)-tobramycin could ... overcome these
limitations by packing tobramycin into
liposomes, which, by allowing
effective penetration of the antibiotic into
the bacterial cell, completely
changes the ...
Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
... layers of the bladder that has not yet spread into
the deeper muscle layer. This form of bladder ... therapy, administered via trans-urethral catheter into
The first of two Phase III ... administered by trans-urethral catheter directly into
the bladder, ...
King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use
... varying doses of niacin. Volunteers were broken into
two groups (fed and fasted) and were provided ... if orally over-consumed, turn dissolved tablets into
a thick gelatinous mixture making it difficult to draw into
a syringe, or produce a mild burning sensation in ...
Alfacell Provides Shareholder Update
... with this function may allow more drug to come into
the cells and cause death of the cancer. Another ... also known to be elevated when normal cells turn into
mesothelioma cells, and high levels of this gene ... arena. One such experiment we are looking into
is whether Onconase can be used as routine tool ...
HEALTHPOINT-Sponsored Venous Leg Ulcer Clinical Trial Enrolls First Subject for Second Phase II Study
... has enrolled the first of a planned 235 subjects into
a Phase II dose response study investigating an ... in 18 states.
"The start of enrollment into
this multi-center, randomized trial is an ... two plausible dose frequencies. Enrollment into
the trial is preceded by screening and run-in ...
Researchers Say More Aggressive Vitamin D Supplementation Needed in Obese Cancer Patients
... -- Body mass index (BMI) should be taken into
account when assessing a cancer patient's vitamin ... dietary recommendations for vitamin D do not take into
account a patient's BMI," said Carolyn ... patients (BMI <30 kg/m2). BMI should be taken into
account when assessing a patient's vitamin D ...
When It Comes to Natural Remedies for Hormonal Balance, the Proof Is in the Clinical Research
... estrogens, obtained from pregnant mare's urine, into
a woman's body, increased rates of breast cancer ... year period in which a woman's body transitions into
Femmenessence does not introduce any foreign hormones into
the system. It simply supports the body's ability ...
Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cancer Research
... will support the translation of discoveries into
medical products with the potential to prolong ... the translation of Dr. Bell's promising research into
important cancer therapeutics," stated David H. ... working together to translate biological research into
cutting edge therapies quickly and effectively," ...
VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
... collecting and fusing multiple vital signs into
a validated, actionable health index--helping ... sensor technology and wireless data transmission into
a lightweight, comfortable "smart garment" that ... software to fuse data from multiple vital signs into
a single index of health status that will provide ...
Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk
... no echocardiographic exclusion criteria for entry into
these trials and there is no monitoring by an ... which in most cases are capable of continuing into
2023 without taking into
account any patent term extensions or other ...
WORLD'S First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center
... Surgical System to successfully implant a kidney into
a living recipient. This procedure ... is just large enough to introduce the kidney into
the recipient's body. It is approximately ... to this surgery, implantation of the donor kidney into
the recipient required traditional open surgery. ...
IBM and EU Partners Create a Better Way to Fight AIDS Virus
... but using analytic technologies to take into
account treatment response information from ... mathematical prediction models that not only take into
account the patient's own history, but tap into
the wealth of information that EuResist ...
CuraGen Updates CR011-vcMMAE Data at ASCO
... the maximum tolerated dose and has expanded into
a Phase II open-label, multi-center study. The ... session. Thirty-six patients were enrolled into
this Phase II open-label, multi-center trial that ... because they expand the activity of CR011 into
patients with metastatic breast cancer and open ...
Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials
... in the RECIST Working Group, has incorporated into
its RECIST website at http://www.recist.com ... respect to incorporation of the RECIST criteria into
Independent Review Charters for regulatory ... of incorporating the new RECIST criteria into
medical imaging services to meet immediate demand ...
Novel Vaccine Approach Offers Hope in Fight Against HIV
... used in this animal study might be translated into
an HIV vaccine for humans. If the technique leads ... approach taken in the current study was divided into
two phases. In the first phase, the research team ... SIV-specific immunoadhesins was engineered into
a carrier virus designed to deliver the DNA to ...
Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
... a syringe and packaging components that take into
account some of the challenges many rheumatoid ... a syringe and packaging components that take into
account many of the dexterity challenges RA ... We have designed a syringe that that takes into
account some of the challenges that come with ...
One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials
... its ability to translate scientific discoveries into
practical application," said Ron Kudla, executive ... 33 showed that the compound is absorbed rapidly into
the bloodstream, and has a pharmacokinetic ... option to build the most appropriate therapies into
treatment programs and fit the needs of ...
Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
... diagnostic and therapeutic agents across the BBB into
the central nervous system ("CNS"). The claims ... with potential partners to advance NeuroTrans(TM) into
clinical trials in neurodegenerative diseases."
... therapeutic agents across the blood-brain barrier into
the central nervous system; that the allowed ...
Autism Genes Discovered; Help Shape Connections Among Brain Cells
... opens the door to more focused investigations into
the causes of autism disorders," said Philip R. ... point for translating biological knowledge into
future autism treatments." The hospital's Center ... organization, dedicated to funding research into
the causes, prevention, treatments and a cure for ...
University of California Los Angeles Selects Velos eResearch
"Now our senior leadership will be able to log into
the system and be able to access the data they ... processes.
"We look forward to moving into
a system that will allow us to track studies and ... transmitted by email and fax and manually keyed into
the old database. With the new system, the TORI ...
Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin
... associated with translating this approach into
an effective and safe vaccine based on live ... to bring this vaccine over the finish line and into
widespread use to prevent the devastating ... Center -- findings that were never translated into
a vaccine development effort because the task was ...
Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical Trial in IgA Nephropathy
... and neutralize chemokine-mediated inflammation into
clinical trials. CCL2-LPM has shown a favorable ... significantly decreased the influx of leukocytes into
the kidney and resulted in less kidney mesangial ... leukocytes to become activated and to migrate into
the kidney where they perpetuate inflammation. ...
Prometheus and Rosetta Genomics Announce License and Collaboration Agreement
... Molecular Diagnostics to Mark Prometheus' Entry into
Oncology Market; Rosetta to Receive Milestones ... therapy and are ideally suited to lead our entry into
the oncology market, while complementing our ... based on microRNAs. We are delighted to enter into
this comprehensive partnership with Prometheus," ...
Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
... clinical-stage programs through the clinic and into
Dr. Rioux said, "I am excited ... year.
In November, 2008, Raptor entered into
an agreement with the Centre Hospitalier ... clinical-stage programs through the clinic and into
the market; that the Company's pipeline could ...
Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
... (MSCs) can be potentiated by introducing Ad5IGF-1 into
the cells while they are being processed outside of the body or ex vivo. Upon reintroduction into
the body, these Ad5IGF-1 activated stem cells ... which are processed ex vivo before reintroduction into
the body, tend to loose certain capabilities ...
Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial
... vessel support. The first patient was enrolled into
the second stage of the ABSORB clinical trial at ... started with balloon angioplasty, which evolved into
bare metal stents and then drug eluting metal ... have been eager to enroll their patients into
the second stage of the trial," said John ...
Another LNA-based RNA Inhibitor Enters Clinical Trials
the fourth LNA-based drug has been brought into
the clinic. In the USA
several patients with ... the fourth LNA-based drug that has been brought into
in record time either by ourselves or ... to seeing other new LNA-based compounds advance into
across a range of therapeutic ...
DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program
... and other matters, patients were randomized into
multiple titration regimens. After achieving an ... screened patients to stable pain control and into
the maintenance period (see above), the ... pathway for approval, our intentions to enter into
collaborations or further develop the program are ...
DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology
... San Diego based biomedical company. Integrated into
DSM's Trancerta(R) Drug Delivery platform, this ... leveraging its competences in Materials Sciences into
Life Sciences applications.
MediVas' ... deal we bring in the first biodegradable polymer into
DSM's Biomedical portfolio, which significantly ...
Cancer Research 'David' Hopes to Slay 'Cancer Goliath'
... agent resulting from a pre-treated serum injected into
a particular large animal. The serum causes the ... antibody which in turn is injected into
a special strain of mice that has naturally ... breast cancer. (The injected pre-treated serum into
the large animal appears to give the animal ...
Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
... evidence that the transplanted cells integrated into
the nervous system of the host. The rats had a ... cells to be readily accepted by and integrated into
a human nervous system, such as in an ALS or a ... therapy is that the cells can integrate into
the host to provide function in addition to ...
Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C
... and commercialization agreement entered into
in June 2006.
(Logo: ... study continued to follow all patients randomized into
the trial on an intention-to-treat (ITT) basis ... and commercialization agreement entered into
in June 2006. HGS and Novartis will ...